Day: May 14, 2026

Hong Kong Corporate News

Central China Real Estate Announces April 2026 Unaudited Contracted Sales Data and Year-on-Year Performance Update 1

Minichart

May 14, 2026

Central China Real Estate Limited - April 2026 Unaudited Con...

Continue Reading 0

Hong Kong Corporate News

XPeng Inc. Announces Board Meeting and Q1 2026 Earnings Conference Call Details

Minichart

May 14, 2026

XPeng Inc. Announces Board Meeting and Q1 2026 Results Relea...

Continue Reading 0

Hong Kong Corporate News

CStone Pharmaceuticals Announces On-Market Share Repurchase Plan Reflecting Confidence in R&D and Business Growth

Minichart

May 14, 2026

CStone Pharmaceuticals Announces On-Market Share Repurchase ...

Continue Reading 0

Hong Kong Corporate News

ITC Properties Group Completes HK$52.87 Million Share Placement to Fund AI and Web3 Expansion – May 2026

Minichart

May 14, 2026

ITC Properties Group Limited: Completion of Placing of New S...

Continue Reading 0

Hong Kong Corporate News

Seazen Group Limited Announces April 2026 Unaudited Sales and Property Lease Statistics

Minichart

May 14, 2026

Seazen Group Limited April 2026 Operating Statistics - Inves...

Continue Reading 0

Hong Kong Corporate News

Water Oasis Group Limited Announces Board Meeting to Approve 2026 Interim Results and Dividend Consideration 1

Minichart

May 14, 2026

Water Oasis Group Limited Announces Board Meeting to Approve...

Continue Reading 0

SGX Financial statements

Incredible Holdings Ltd. Q3 & 9M 2026 Financial Results: Revenue Drops, No Dividend Declared

Minichart

May 14, 2026

Incredible Holdings Ltd. Q3 FY2026 Financial Review: A Chall...

Continue Reading 0

Hong Kong Corporate News

Shanghai Henlius Biotech Receives Approval for Phase 1 Clinical Trial of HLX48 Bispecific ADC Targeting EGFR and c-MET in Australia 1

Minichart

May 14, 2026

Shanghai Henlius Biotech Announces Australian Approval for H...

Continue Reading 0

SGX Financial statements

SingPost Strategy Update 2026: Sustainable Growth, Digital Transformation, and 30-50% Dividend Payout Policy

Minichart

May 14, 2026

SingPost Strategy Update: Financial Analysis and Investment ...

Continue Reading 0

Hong Kong Corporate News

Shanghai Henlius Biotech Doses First Patient in Phase 1 Trial of HLX97 (KAT6A/B Inhibitor) for Advanced Solid Tumours in China

Minichart

May 14, 2026

Shanghai Henlius Biotech, Inc. Doses First Patient in Phase ...

Continue Reading 0